UY34479A - PHARMACEUTICAL COMPOSITION THAT INCLUDES ISOMETAMIDIUM CHLORIDE IN SOLUTION FOR THE TREATMENT OF TRIPANOSOMIASIS IN ANIMALS - Google Patents

PHARMACEUTICAL COMPOSITION THAT INCLUDES ISOMETAMIDIUM CHLORIDE IN SOLUTION FOR THE TREATMENT OF TRIPANOSOMIASIS IN ANIMALS

Info

Publication number
UY34479A
UY34479A UY0001034479A UY34479A UY34479A UY 34479 A UY34479 A UY 34479A UY 0001034479 A UY0001034479 A UY 0001034479A UY 34479 A UY34479 A UY 34479A UY 34479 A UY34479 A UY 34479A
Authority
UY
Uruguay
Prior art keywords
tripanosomiasis
animals
treatment
solution
pharmaceutical composition
Prior art date
Application number
UY0001034479A
Other languages
Spanish (es)
Inventor
Gonzalez Cordero Auristela
Ochoa Roviro Alberto
Original Assignee
Invest Farmaceuticas Y Veterinarias S L
Reveex De Venezuela C A Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46963763&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY34479(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Invest Farmaceuticas Y Veterinarias S L, Reveex De Venezuela C A Lab filed Critical Invest Farmaceuticas Y Veterinarias S L
Publication of UY34479A publication Critical patent/UY34479A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Communication Control (AREA)

Abstract

No escanear figura.
UY0001034479A 2012-01-24 2012-11-29 PHARMACEUTICAL COMPOSITION THAT INCLUDES ISOMETAMIDIUM CHLORIDE IN SOLUTION FOR THE TREATMENT OF TRIPANOSOMIASIS IN ANIMALS UY34479A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201230092A ES2416004B1 (en) 2012-01-24 2012-01-24 PHARMACEUTICAL COMPOSITION THAT INCLUDES ISOMETAMIDIUM CHLORIDE IN SOLUTION FOR THE TREATMENT OF TRIPANOSOMIASIS IN ANIMALS.

Publications (1)

Publication Number Publication Date
UY34479A true UY34479A (en) 2013-07-31

Family

ID=46963763

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034479A UY34479A (en) 2012-01-24 2012-11-29 PHARMACEUTICAL COMPOSITION THAT INCLUDES ISOMETAMIDIUM CHLORIDE IN SOLUTION FOR THE TREATMENT OF TRIPANOSOMIASIS IN ANIMALS

Country Status (16)

Country Link
AP (1) AP2014007798A0 (en)
AR (1) AR089037A1 (en)
BR (1) BR112014016926A8 (en)
CL (1) CL2014001780A1 (en)
CO (1) CO6990714A2 (en)
CR (1) CR20140278A (en)
DO (1) DOP2014000161A (en)
EC (1) ECSP14010152A (en)
ES (1) ES2416004B1 (en)
GT (1) GT201400159A (en)
MA (1) MA35868B1 (en)
MX (1) MX2014008172A (en)
NI (1) NI201400075A (en)
PE (1) PE20141472A1 (en)
UY (1) UY34479A (en)
WO (1) WO2013110830A1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2024008B (en) * 1978-06-28 1983-02-16 Merck & Co Inc Compositions for treating trypanosomiasis infections
GB8805286D0 (en) * 1988-03-05 1988-04-07 Schering Agrochemicals Ltd Trypanocides
US5496830A (en) * 1994-09-14 1996-03-05 Johns Hopkins University Inhibition of hemoflagellates by camptothecin compounds
DE19854143A1 (en) * 1998-11-24 2000-05-25 Chambord Ltd Antiprotozoal composition useful for treating e.g. piroplasmosis, malaria and sleeping sickness comprises pentamidine and an additional biocide
FR2819188B1 (en) * 2001-01-08 2003-03-14 Virbac Sa WATER-SOLUBLE PULVERULENT OR GRANULATED COMPOSITIONS BASED ON PHENANTHRIDINES AND USES THEREOF
AR060926A1 (en) * 2007-05-14 2008-07-23 Ciriaco Quiroga PROPOFOL TRANSPARENT ANESTHETIC SOLUTION, WITH LOW VENOUS IRRITATION.
KR20080102010A (en) * 2007-05-17 2008-11-24 대원제약주식회사 Composition for injection including propofol and method of preparing the same
DE102008007381A1 (en) * 2008-02-01 2009-08-13 Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co.Kg Amidines and guanidines and their derivatives for the treatment of diseases
WO2011042565A2 (en) * 2009-10-09 2011-04-14 Instituut Voor Tropische Geneeskunde Antiprotozoal activity

Also Published As

Publication number Publication date
CL2014001780A1 (en) 2014-10-24
ECSP14010152A (en) 2015-08-31
ES2416004B1 (en) 2014-01-28
MX2014008172A (en) 2014-10-06
MA35868B1 (en) 2014-12-01
AR089037A1 (en) 2014-07-23
ES2416004A1 (en) 2013-07-29
CO6990714A2 (en) 2014-07-10
AP2014007798A0 (en) 2014-07-31
BR112014016926A2 (en) 2017-06-13
WO2013110830A1 (en) 2013-08-01
PE20141472A1 (en) 2014-11-05
NI201400075A (en) 2015-04-13
GT201400159A (en) 2015-11-19
CR20140278A (en) 2014-12-02
DOP2014000161A (en) 2014-08-15
BR112014016926A8 (en) 2017-07-04

Similar Documents

Publication Publication Date Title
CY1124729T1 (en) PHARMACEUTICAL FORMS OF ENZALUTHAMIDE
NI201600071A (en) AUTOTAXIN INHIBITOR COMPOUNDS
CL2017001204A1 (en) 6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors
CL2016000153A1 (en) Glioxamide substituted pyrrolamide derivatives and their use as medicines for the treatment of hepatitis b
EA201692301A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
CL2016002072A1 (en) 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as bace1 inhibitors for the treatment of Alzheimer's disease
CR20150316A (en) COMPOUNDS AND THEIR EMPLOYMENT METHODS
UY33863A (en) METHODS AND MEDICINES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
UY34657A (en) ? MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF DISEASES ?.
UA116648C2 (en) FUMARATS AS A PRODUCT AND THEIR USE IN THE TREATMENT OF DIFFERENT DISEASES
UY34165A (en) ? ALDH-2 HUMAN MITOCONDRIAL COMPOUNDS FOR ADDICTION TREATMENT ?.
ES2765949T8 (en) Therapy involving antibodies to claudin 18.2 for cancer treatment
GT201400063A (en) BENZILINDAZOLS REPLACED FOR USE AS INHIBITORS OF QUINASA BUB1 IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
UY34885A (en) ANTI-MESOTHELINE UNION PROTEINS
UY34545A (en) NOVEDOSE DIHYDROPIRIMIDINOISOQUINOLINONES AND PHARMACEUTICAL COMPOSITIONS OF THE SAME FOR THE TREATMENT OF INFLAMMATORY DISORDERS.
ECSP14030779A (en) NAMPT INHIBITORS
NI201600070A (en) AUTOTAXIN TETRAYCLIC INHIBITORS
UY34615A (en) NEW USEFUL COMPOUNDS FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES.
CL2015002488A1 (en) Novel abexinostat salt, related crystalline form, method of preparation of this and the pharmaceutical compositions containing it
ECSP14011792A (en) IAP INHIBITORS
CL2014001862A1 (en) Compounds derived from substituted moropholinyl, useful as mogat-2 inhibitors; pharmaceutical composition that includes them; use in the treatment of hypertriglyceridemia.
AR094241A1 (en) CICLESONIDE FOR THE TREATMENT OF RESPIRATORY ROAD DISEASE IN HORSES
PE20150167A1 (en) (R) -NIFURATEL, ITS USE FOR THE TREATMENT OF INFECTIONS AND SYNTHESIS OF (R) AND (S) -NIFURATEL
UY34575A (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DIABETES AND / OR OBESITY
UY34579A (en) INHALATION DEVICE FOR POWDER DRUGS

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20211216